If you are wondering whether Syndax Pharmaceuticals at around US$23.77 is still offering value after a strong run, the next ...
Interest in Ichor Holdings (ICHR) has picked up after several analyst upgrades highlighted expectations for better gross margins, ongoing operational restructuring, and supportive semiconductor demand ...
Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results